UMass Chan Affiliations
Meyers Primary Care InstituteDepartment of Medicine, Division of Gastroenterology
Department of Medicine, Division of Cardiovascular Medicine
Department of Emergency Medicine
Document Type
Journal ArticlePublication Date
2011-12-01Keywords
*Drug ToxicityGene Expression Profiling
Genomics
Humans
Metabolomics
MicroRNAs
Molecular Biology
Proteomics
Systems Biology
Medical Toxicology
Molecular Biology
Toxicology
Metadata
Show full item recordAbstract
The advancement of molecular biologic techniques and their capabilities to answer questions pertaining to mechanisms of pathophysiologic events have greatly expanded over the past few years. In particular, these opportunities have provided researchers and clinicians alike the framework from with which to answer clinical questions not amenable for elucidation using previous, more antiquated methods. Utilizing extremely small molecules, namely microRNA, DNA, protein, and nanoparticles, we discuss the background and utility of these approaches to the progressive, practicing physician. Finally, we consider the application of these tools employed as future bedside point of care tests, aiding in the ultimate goal of unsurpassed patient care.Source
J Med Toxicol. 2011 Dec;7(4):288-94. Link to article on publisher's site
DOI
10.1007/s13181-011-0189-8Permanent Link to this Item
http://hdl.handle.net/20.500.14038/31062PubMed ID
22072091Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1007/s13181-011-0189-8